Section: Aquatic Bacteria

Epizootic Ulcerative Syndrome in Fish: Pathogen Identification and Management

Introduction

Epizootic Ulcerative Syndrome (EUS) is a devastating, seasonally recurring disease affecting a wide range of freshwater and estuarine fish species across Asia, Africa, Australia, and North America. The disease is characterized by severe, progressive necrotizing ulcerative lesions of the skin and underlying musculature, often leading to high morbidity and mortality. While EUS is primarily caused by the invasive oomycete Aphanomyces invadans, the clinical presentation is frequently complicated by secondary bacterial infections, most notably motile aeromonads such as Aeromonas hydrophila and Aeromonas veronii [1, 2]. This article provides an exhaustive review of the etiological agent, diagnostic approaches including histopathology and molecular assays, and integrated management strategies for EUS in aquaculture and wild fish populations.

Etiology and Pathogen Biology

Primary Agent: Aphanomyces invadans

The primary causative agent of EUS is the oomycete Aphanomyces invadans. Although oomycetes are phylogenetically distinct from true fungi, they are often grouped with fungal pathogens in veterinary mycology due to their filamentous growth and similar disease presentations. A. invadans is a water mold that produces motile zoospores capable of chemotactic attraction to fish skin. The pathogen invades through the epidermis and dermis, proliferating within the underlying muscle tissue and eliciting a severe granulomatous inflammatory response [3, 4].

The virulence of A. invadans is mediated by several factors, including the secretion of proteolytic enzymes and the expression of molecular chaperones such as Lhs1, which contributes to protein folding and stress tolerance within the host environment [5]. The oomycete's ability to survive and sporulate in aquatic environments facilitates rapid transmission, particularly during periods of environmental stress such as flooding, temperature fluctuations, and low dissolved oxygen [6].

Secondary Bacterial Invaders

While A. invadans is the primary etiological agent, the ulcerative lesions characteristic of EUS are frequently colonized by opportunistic bacteria. Aeromonas hydrophila and Aeromonas veronii are the most commonly isolated secondary pathogens [1, 2]. These Gram-negative, facultative anaerobic rods produce a range of exotoxins including hemolysins, cytotoxins, and proteases that exacerbate tissue necrosis and systemic infection. The synergistic interaction between the oomycete and bacterial pathogens often results in a more severe clinical outcome than infection with either agent alone [7, 8].

Epidemiology and Risk Factors

EUS outbreaks are strongly associated with environmental stressors. Flooding events, as documented in Kerala, India, have been linked to increased disease incidence due to the introduction of contaminated water, disruption of fish immune function, and physical trauma from suspended sediments [6]. Similarly, outbreaks in the Kavango-Zambezi and Great Limpopo transfrontier conservation areas of Zimbabwe have demonstrated a seasonal pattern, with peak prevalence during the cooler months when water temperatures favor oomycete sporulation and zoospore motility [9].

The disease has a broad host range, affecting over 100 fish species including both cultured and wild populations. Recent reports have documented EUS in eastern mosquitofish (Gambusia holbrooki) from South Carolina and smallmouth bass (Micropterus dolomieu) from West Virginia, indicating an expanding geographic distribution in North America [3, 4]. The introduction of A. invadans into naive ecosystems can have catastrophic effects on native fish biodiversity.

Clinical Signs and Gross Pathology

The clinical progression of EUS follows a characteristic sequence. Initial signs include erythema and petechial hemorrhages on the body surface, particularly around the operculum, caudal peduncle, and ventral abdomen. As the disease advances, these areas develop into focal, raised, pale lesions that rapidly ulcerate. The ulcers are typically deep, extending into the underlying musculature, and often have a necrotic, hemorrhagic center with a raised hyperemic border.

In chronic cases, the ulcers may become secondarily infected with saprophytic fungi and bacteria, leading to a foul-smelling, liquefactive necrosis. Affected fish exhibit lethargy, anorexia, abnormal swimming behavior, and increased mortality. Morbidity rates can exceed 80 percent in naive populations, with mortality rates varying depending on water temperature, host species, and the presence of co-infections [9, 6].

Diagnostic Approaches

Histopathology

Histopathological examination remains the gold standard for definitive diagnosis of EUS. Tissue samples should be collected from the advancing margin of active ulcers, including both the necrotic center and adjacent healthy tissue. Samples are fixed in 10 percent neutral buffered formalin, processed routinely, and stained with hematoxylin and eosin (H&E). Special stains such as Grocott's methenamine silver (GMS) or periodic acid-Schiff (PAS) can enhance visualization of oomycete hyphae.

The characteristic histopathological finding in EUS is a severe, chronic granulomatous inflammation with extensive myonecrosis. Within the necrotic muscle, broad, aseptate, branching hyphae of A. invadans are observed, often surrounded by a zone of epithelioid macrophages and multinucleated giant cells. The hyphae are typically 7 to 25 micrometers in diameter and exhibit non-dichotomous branching. The presence of these hyphae within the deep musculature, accompanied by a granulomatous response, is considered pathognomonic for EUS [3, 4].

Molecular Diagnostics

Molecular detection methods offer high sensitivity and specificity for the identification of A. invadans, particularly in early infections or when histopathology is inconclusive. Conventional polymerase chain reaction (PCR) assays targeting the internal transcribed spacer (ITS) region of ribosomal DNA have been widely used. More recently, a real-time quantitative PCR (qPCR) assay has been developed that allows for rapid detection and quantification of A. invadans DNA in fish tissues and water samples [10]. This assay demonstrates high analytical sensitivity, with a limit of detection as low as 10 fg of genomic DNA, and can differentiate A. invadans from other oomycetes.

For bacterial co-infections, molecular characterization of Aeromonas isolates is performed using 16S rRNA gene sequencing or species-specific PCR assays targeting virulence genes such as aerA (aerolysin) and hlyA (hemolysin) [2]. Multiplex PCR panels that simultaneously detect A. invadans and common bacterial pathogens are under development and may improve diagnostic efficiency in field settings.

Culture and Isolation

Isolation of A. invadans in culture is technically challenging due to its slow growth and overgrowth by faster-growing bacteria and fungi. Selective media containing antibiotics such as penicillin, streptomycin, and oxolinic acid are used to suppress contaminants. Incubation at 20 to 25 degrees Celsius for 5 to 10 days is required for visible colony formation. Colonies appear as white, cottony, submerged mycelia. Identification is confirmed by morphological examination of zoospore production and molecular sequencing [10, 4].

Immunological Methods

Serological assays, including enzyme-linked immunosorbent assay (ELISA), have been developed for the detection of A. invadans antigens in fish tissues. However, these methods are less commonly used in routine diagnostics compared to histopathology and PCR. The development of monoclonal antibodies against specific oomycete proteins may improve the sensitivity and specificity of future immunodiagnostic tests.

Diagnostic Decision Tree

The following Mermaid diagram outlines a recommended diagnostic workflow for suspected EUS cases.

flowchart TD
    A[Suspected EUS Case], > B{Clinical Signs}
    B, >|Deep Ulcers, Hemorrhages| C[Gross Necropsy]
    C, > D[Tissue Collection]
    D, > E[Histopathology]
    E, > F{Hyphae in Muscle?}
    F, >|Yes| G[Granulomatous Myositis?]
    G, >|Yes| H[Confirm A. invadans]
    F, >|No| I[Consider Other Etiologies]
    H, > J[PCR/qPCR for A. invadans]
    J, > K{Positive?}
    K, >|Yes| L[Confirmed EUS]
    K, >|No| M[Review Histology]
    D, > N[Bacterial Culture]
    N, > O[Aeromonas spp.?]
    O, >|Yes| P[Antimicrobial Susceptibility]
    O, >|No| Q[Consider Other Bacteria]
    L, > R[Implement Management]

Management and Control Strategies

Biosecurity and Environmental Management

Prevention of EUS relies on robust biosecurity measures. Quarantine protocols for introduced fish, disinfection of equipment and water sources, and control of fish movement between water bodies are essential to prevent the introduction of A. invadans into naive populations. Environmental management includes maintaining optimal water quality parameters (temperature, dissolved oxygen, pH), reducing organic load, and avoiding overcrowding. Following flooding events, rapid removal of dead fish and application of lime to stabilize pH can reduce disease transmission [11, 6].

Chemotherapy

There are no approved chemotherapeutic agents that effectively eliminate A. invadans from infected fish. However, topical application of antiseptics such as potassium permanganate or formalin to ulcerative lesions may reduce secondary bacterial infections. In aquaculture settings, the use of antibiotics for bacterial co-infections should be guided by antimicrobial susceptibility testing to minimize the development of resistance [12]. The widespread and often indiscriminate use of antibiotics in aquaculture is a major public health concern, as it contributes to the selection of resistant bacterial strains [11, 12].

Immunomodulation and Vaccination

Immunomodulatory approaches using plant-based extracts have shown promise in enhancing fish resistance to EUS. For example, ashwagandha (Withania somnifera) and bhringaraj (Eclipta alba) leaf extracts have demonstrated immunostimulatory effects in fish, including increased phagocytic activity, respiratory burst, and antibody production against A. invadans antigens [13, 14]. These natural products offer a sustainable alternative to chemotherapeutic agents, particularly in hill aquaculture and organic farming systems.

Vaccination strategies against A. invadans are still in the experimental stage. However, significant progress has been made in developing vaccines against bacterial co-infections. A chitosan-polymer based nanovaccine against Aeromonas veronii has been shown to induce protective immunity in red tilapia following immersion vaccination [7]. Similarly, bivalent whole-cell inactivated vaccines against motile Aeromonas septicemia (MAS) have demonstrated efficacy in catfish species [8]. These vaccines, if combined with oomycete antigens, could provide broad-spectrum protection against the EUS disease complex.

Deep Learning and Surveillance

Recent advances in computational biology have enabled the development of deep learning models for the automated detection of EUS lesions and the parasitic copepod Argulus in fish aquaculture. These models, based on convolutional neural networks, can analyze images of fish in real-time and alert farmers to early signs of disease, facilitating rapid intervention [15]. Such tools represent a significant step forward in precision aquaculture and disease surveillance.

Conclusion

Epizootic Ulcerative Syndrome remains a major threat to global fish health and aquaculture sustainability. The disease is caused by the oomycete Aphanomyces invadans, with secondary bacterial infections, particularly by Aeromonas species, exacerbating clinical outcomes. Accurate diagnosis relies on histopathological examination and molecular detection methods such as qPCR. Effective management requires an integrated approach combining biosecurity, environmental control, judicious use of antimicrobials, immunomodulation, and emerging technologies such as deep learning-based surveillance. Continued research into pathogen virulence mechanisms, host immune responses, and vaccine development is essential for the long-term control of this devastating disease.

References

[1] Iqbal A, Kiran S, Haider A, et al. Chitosan and polyacrylic acid engineered AlFeO(3) validated degradation of rhodamine B and resistant Pseudomonas aeruginosa of epizootic ulcerative syndrome in Ctenopharyngodon idella with mechanistic insights. Int J Biol Macromol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41654056/

[2] Tooba L, Shahzad A, Zahid M, et al. Molecular characterization of Aeromonas hydrophila isolates from diseased fishes in district Kasur, Punjab, Pakistan. Braz J Biol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35019106/

[3] Bruce TJ, Trettin CC, Noel ZA, et al. A case study of epizootic ulcerative syndrome (EUS) caused by Aphanomyces invadans in eastern mosquitofish (Gambusia holbrooki) from the headwaters of Charleston Harbor, South Carolina. J Fish Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38031507/

[4] Walsh HL, Blazer VS, Mazik PM. Identification of Aphanomyces invadans, the cause of epizootic ulcerative syndrome, in smallmouth bass (Micropterus dolomieu) from the Cheat River, West Virginia, USA. J Fish Dis. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34114662/

[5] Iberahim NA, Sood N, Pradhan PK, et al. The chaperone Lhs1 contributes to the virulence of the fish-pathogenic oomycete Aphanomyces invadans. Fungal Biol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/33213782/

[6] Das BC, Haridas DV, Jacob N, et al. Outbreaks of epizootic ulcerative syndrome in Kerala, India following episodes of flooding. Dis Aquat Organ. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33629661/

[7] Sukkarun P, Kitiyodom S, Yostawornkul J, et al. Chitosan-polymer based nanovaccine as promising immersion vaccine against Aeromonas veronii challenge in red tilapia (Oreochromis sp.). Fish Shellfish Immunol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35988712/

[8] Rahman MM, Rahman MA, Hossain MT, et al. Efficacy of bi-valent whole cell inactivated bacterial vaccine against Motile Aeromonas Septicemia (MAS) in cultured catfishes (Heteropneustes fossilis, Clarias batrachus and pangasius pangasius) in Bangladesh. Saudi J Biol Sci. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35844412/

[9] Sibanda S, Pfukenyi DM, Hang'ombe B, et al. Epidemiology of epizootic ulcerative syndrome (EUS) in fish in the main water bodies of the Kavango-Zambezi and Great Limpopo transfrontier conservation areas of Zimbabwe. J Fish Dis. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36504110/

[10] Ho DT, Kim N, Lee Y, et al. Development of a rapid and sensitive real-time diagnostic assay to detect and quantify Aphanomyces invadans, the causative agent of epizootic ulcerative syndrome. PLoS One. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37319186/

[11] Rasul MN, Hossain T, Sifat-Un-Nuri, et al. Disease Prevalence, Usage of Aquaculture Medicinal Products and Their Sustainable Alternatives in Freshwater Aquaculture of North-Central Bangladesh. Vet Med Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40028709/

[12] Kawsar MA, Alam MT, Pandit D, et al. Status of disease prevalence, drugs and antibiotics usage in pond-based aquaculture at Narsingdi district, Bangladesh: A major public health concern and strategic appraisal for mitigation. Heliyon. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35284681/

[13] Debnath C, Sahoo L. Harnessing the immunomodulatory potential of ashwagandha (Withania somnifera) against epizootic ulcerative syndrome: a sustainable approach for hill aquaculture. Dis Aquat Organ. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39782093/

[14] Kumar V, Das BK, Swain HS, et al. Immunomodulatory Potency of Eclipta alba (Bhringaraj) Leaf Extract in Heteropneustes fossilis against Oomycete Pathogen, Aphanomyces invadans. J Fungi (Basel). 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36836257/

[15] Hamzaoui M, Ould-Elhassen Aoueileyine M, Bouallegue S, et al. Enhanced detection of Argulus and epizootic ulcerative syndrome in fish aquaculture through an improved deep learning model. J Aquat Anim Health. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40662570/